Last update 01 Nov 2024

Rottapharm Madaus GmbH

Subsidiary Company|
Germany

Overview

Related

7
Drugs associated with Rottapharm Madaus GmbH
Dexloxiglumide
Target
CCKA
Mechanism
CCKA antagonists
Active Org.
Allergan Ltd. (Ireland)
Originator Org.
Rottapharm SpARottapharm SpA
Active Indication
Irritable Bowel Syndrome
Inactive Indication
Dyspepsia [+2]
Drug Highest PhasePhase 3
First Approval Ctry. / Loc.-
First Approval Date-
Andolast
Target
KCa
Mechanism
KCa agonists
Active Org.
Rottapharm SpARottapharm SpA
Originator Org.
Rottapharm SpARottapharm SpA
Active Indication
Asthma [+2]
Inactive Indication-
Drug Highest PhasePhase 3
First Approval Ctry. / Loc.-
First Approval Date-
CR-4056
Target
imidazoline receptor
Mechanism
imidazoline receptor modulators
Active Org.
Rottapharm SpARottapharm SpA [+1]
Originator Org.
Rottapharm SpARottapharm SpA
Active Indication
Osteoarthritis [+1]
Inactive Indication
Acute Pain [+1]
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with Rottapharm Madaus GmbH
Login to view more data
0 Patents (Medical) associated with Rottapharm Madaus GmbH
Login to view more data
100 Deals associated with Rottapharm Madaus GmbH
Login to view more data
100 Translational Medicine associated with Rottapharm Madaus GmbH
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 17 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
7
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Itriglumide
 ( CCKB )		Sleep Apnea Syndromes
More
Discontinued
Dexloxiglumide
 ( CCKA )		Sleep Apnea Syndromes
More
Discontinued
CR-4056
 ( imidazoline receptor )		Cancer Pain
More
Pending
Andolast
 ( KCa )		Rhinitis, Allergic
More
Pending
Neboglamine
 ( NMDA receptor )		Schizophrenia
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free